DURHAM, N.C.--(BUSINESS WIRE)--restor3d, a leader in personalized 3D-printed orthopedic solutions, announced the launch of MyFit by restor3d Digital Suite, a new patient engagement ecosystem designed to provide patients with greater visibility into their personalized orthopedic journey while creating a seamless connection between patients, surgeons, and long-term clinical outcomes.
restor3d Launches MyFit by restor3d Digital Suite, Expanding Personalized Orthopedic Care Beyond the Operating Room
4 min read Premium comments
launchrestor3d3D-printed orthopedic solutionsMyFit by restor3d Digital Suitepatient engagement ecosystem
“MyFit creates an opportunity to connect three things that are fundamental to the future of personalized orthopedics: the patient experience, the technology used to treat each individual patient, and the outcomes that follow” - Michael Swank, MD
MyFit by restor3d extends restor3d’s commitment to personalization beyond implant design and into the patient experience. Through automated communications and an interactive patient portal, patients can receive updates throughout the creation of their personalized implant, track its status, and, for select procedures, view a 3D model of their personalized design before surgery.
“Personalization has always been at the center of what we do at restor3d, and MyFit by restor3d allows us to bring that same philosophy directly to the patient experience,” said Kurt Jacobus, Chief Executive Officer of restor3d. “Patients undergoing joint replacement are increasingly engaged in their care and want to better understand the technology and treatment designed specifically for them. MyFit by restor3d gives patients a unique connection to their personalized implant while allowing us to continue learning from their outcomes over time.”
The MyFit by restor3d patient engagement ecosystem includes multiple experiences tailored to restor3d’s orthopedic portfolio. MyFit Connect by restor3d provides hip and knee patients with automated SMS updates at key milestones throughout their implant journey, from enrollment and design through manufacturing and surgery readiness. For shoulder and foot and ankle patients, the MyFit by restor3d patient portal provides access to implant status updates and an interactive 3D model of their personalized design. Patients can access the experience using simple identifying information without the need to create or remember a password.
Together, these capabilities are designed to keep patients informed while reducing the administrative burden associated with routine implant status inquiries to their surgeon’s office.
MyFit by restor3d also provides patients with the opportunity to participate in the restor3d Patient-Specific Registry, a prospective, longitudinal registry designed to collect patient-reported outcomes from baseline through five years following surgery. The registry encompasses knee, hip, shoulder, and foot and ankle procedures and is designed to enroll approximately 2,250 patients.
Through direct-to-patient electronic patient-reported outcome collection, restor3d aims to build a growing body of real-world evidence around patient-specific, 3D-printed orthopedic implants while minimizing additional administrative requirements for participating practices. Participating surgeons can receive their patients’ reported outcomes, creating an additional connection between personalized technology and longitudinal patient experience.
“MyFit creates an opportunity to connect three things that are fundamental to the future of personalized orthopedics: the patient experience, the technology used to treat each individual patient, and the outcomes that follow,” said Michael Swank, MD, Imperial Health, Lake Charles, Louisiana. “By giving patients greater visibility into their care while creating a streamlined pathway for long-term outcomes collection, we can continue building the clinical evidence that helps us understand and advance personalized orthopedic care.”
The launch represents another step in restor3d’s broader effort to create a connected ecosystem around personalized orthopedic care. From patient-specific planning and implant design to manufacturing, surgery, patient engagement, and long-term outcomes, restor3d is working to connect each stage of the patient journey through technology and data.
MyFit by restor3d launches September 8, 2026 available to all restor3d surgeons with a restor3d patient-specific case.
For more information about MyFit by restor3d and restor3d’s personalized orthopedic solutions, visit restor3d.com/myfit-digital-solutions.
About restor3d, Inc.
restor3d is a world leader in 3D printed patient specific musculoskeletal implants and driven by the belief that every patient deserves personalized care. The company holds proprietary expertise and intellectual property in 3D printing of osseointegrative materials, AI-based planning and design automation tools, and digital health solutions to provide seamless data-backed care to optimize individual patient outcomes. Alongside its customers, restor3d is reimagining the musculoskeletal reconstruction landscape. More information is available at www.restor3d.com.
Forward-Looking Statements
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements which involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In many cases, forward-looking statements can be identified by terms such as “future,” “believes,” “expects,” “may,” “will,” “should,” “potential,” “estimates,” “intends,” “anticipates” or “plans” or the negative of these terms or other comparable terminology. Forward-looking statements are based upon management’s beliefs, assumptions and current expectations but are subject to known and unknown risks and uncertainties including, without limitation, distribution challenges, market trends and demand, product efficacy and safety concerns, product or raw material availability and other supply constraints. Although management believes that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results. The forward-looking statements included are made only as the date of this release. The company assumes no obligation to update any information or forward-looking statement contained herein, save for any information required to be disclosed by law.
Contacts
Media Contact
Jordan Wagner
VP of Marketing, restor3d
(281) 866-4988
Jordan.wagner@restor3d.com
Author
TH
TJ Halvorson
The De Angelis Group | Orthopedics This Week | MSK Innovations
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
restor3d launched MyFit Digital Suite, a patient engagement ecosystem for its personalized 3D-printed orthopedic solutions. This strategic move aims to enhance patient experience through implant status updates and 3D models, while also facilitating long-term patient-reported outcome collection. This integrated approach could drive adoption by offering differentiated value to patients and surgeons, potentially strengthening restor3d's competitive position in the personalized orthopedics market by building a robust real-world evidence base.
- The suite extends personalization beyond implants into patient engagement, offering updates and 3D models to improve patient understanding and satisfaction, potentially boosting adoption.
- It integrates a Patient-Specific Registry for collecting long-term PROs, providing valuable real-world evidence to support personalized 3D-printed implants and reduce administrative burden for practices.
PhD Lens: Clinical and outcomes impact
restor3d introduced MyFit Digital Suite, a patient engagement ecosystem supporting its personalized 3D-printed orthopedic solutions. This digital platform provides patients with interactive 3D models of their custom implants and status updates. Crucially, it integrates a prospective, longitudinal Patient-Specific Registry to collect patient-reported outcomes for up to five years post-surgery, aiming to build robust real-world evidence for personalized 3D-printed implants across multiple anatomical sites.
- The suite offers digital tools like 3D models and automated updates to enhance patient understanding of their personalized 3D-printed implants, extending the personalization concept.
- It includes a Patient-Specific Registry designed to prospectively collect direct-to-patient electronic PROs from approximately 2,250 patients over five years, generating long-term clinical evidence.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.